JP2012502945A - 乳清及び胸腺機能 - Google Patents
乳清及び胸腺機能 Download PDFInfo
- Publication number
- JP2012502945A JP2012502945A JP2011527299A JP2011527299A JP2012502945A JP 2012502945 A JP2012502945 A JP 2012502945A JP 2011527299 A JP2011527299 A JP 2011527299A JP 2011527299 A JP2011527299 A JP 2011527299A JP 2012502945 A JP2012502945 A JP 2012502945A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- whey protein
- use according
- whey
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
【選択図】なし
Description
本発明に使用できる典型的な組成物は以下の通りである:
栄養素 1リットル当たり
タンパク質(gm): 40
タンパク質(%kcal): 16%
炭水化物(gm): 127
炭水化物(%kcal): 51%
脂肪(gm): 39
脂肪(%kcal): 33%
遊離H2O: 85%
ビタミンA(IU): 4300(ベータカロテンとしてのビタミンA活性約37%を含む)
ベータ−カロテン(mg): 上記参照
ビタミンD(IU): 272
ビタミンE(IU): 30
ビタミンK(mcg): 50
ビタミンC(mg): 340
チアミン−B1(mg): 2
リボフラビン−B2(mg): 2.4
ナイアシン(mg): 28
ビタミンB6(mg): 4
葉酸(mcg): 540
パントテン酸(mg): 14
ビタミンB12(mcg):8 133%
ビオチン(mcg): 400
コリン(mg): 452
タウリン(mg): 100
L−カルニチン(mg): 100
ナトリウム(mg): 560
ナトリウム(mEq): 24.3
カリウム(mg): 1500
カリウム(mEq): 38.5
クロライド(mg): 1000
クロライド(mEq): 28.2
カルシウム(mg): 800
カルシウム(mEq): 40
リン(mg): 700
マグネシウム(mg): 300
鉄(mg): 18
ヨウ素(mcg): 148
銅(mg): 2
亜鉛(mg): 24
マンガン(mg): 2.8
セレン(mcg): 50
モリブデン(mcg): 120
クロム(mcg): 40
Claims (15)
- 胸腺の機能及び/又は健康を維持又は改善する組成物を調製するための、乳清又は少なくとも1つの乳清タンパク質画分の使用。
- 前記組成物が成人及び/又は高齢の対象者による摂取を意図するものである、請求項1に記載の使用。
- 前記組成物が、ヒト、ペット、コンパニオンアニマル及び/又は家畜を対象とし、経口投与、経腸投与、局所投与又は非経口投与を意図するものであり、例えば、医薬品、食品、ペットフード製品、食品添加物、栄養補助食品又は飲料である、請求項1又は2に記載の使用。
- 前記乳清タンパク質画分が、ヒト、ウシ、ヒツジ、ヤギ又はラクダの供給源から得られるもの及び/又は乳清タンパク質加水分解産物である、請求項1〜3のいずれか一項に記載の使用。
- 前記乳清タンパク質画分が少なくとも部分的には酵素で加水分解された乳清タンパク質である、請求項1〜4のいずれか一項に記載の使用。
- 前記乳清タンパク質画分が2〜3重量%の範囲のアルギニンを含む、請求項1〜5のいずれか一項に記載の使用。
- 前記組成物が、乳清タンパク質100g当たり、1日のミネラル推奨摂取量の100%以下に相当する量のミネラル、特に、乳清タンパク質100g当たり、最低35mg未満の亜鉛を含む、請求項1〜6のいずれか一項に記載の使用。
- ワクチンの効力を増大させるための、請求項1〜7のいずれか一項に記載の使用。
- 前記乳清又は少なくとも1つの前記乳清タンパク質画分が前記組成物のカロリーの約5〜100°%に相当する量で前記組成物中に含まれ、好ましくは前記組成物のカロリーの約7〜50%、さらにより好ましくは前記組成物のカロリーの約10〜30%が乳清タンパク質に由来する、請求項1〜8のいずれか一項に記載の使用。
- 炭水化物画分がマルトデキストリンを含み、及び/又は脂質画分が、例えば、ヤシ油及び/又はパーム核油の形態で提供される、好ましくは脂質源の60〜80重量%の量の中鎖トリグリセリド(MCT)を含み、1:1〜10:1の範囲のn6:n3比を有する、請求項8に記載の使用。
- リンパ球機能の維持又は再確立及び/又は胸腺萎縮の治療又は予防のための、請求項1〜10のいずれか一項に記載の使用。
- 免疫系を強化するための、特に老化過程における免疫応答を改善するための、請求項1〜11のいずれか一項に記載の使用。
- 栄養失調;肥満;免疫不全、例えば化学療法後又はHIV感染症等;自己免疫障害、例えば全身性紅斑性狼瘡(SLE)、多発性硬化症(MS)又は皮膚筋炎(DM)等;ストレス、例えば慢性ストレス又は社会的ストレス等;感染症、例えば細菌性感染症又はウイルス性感染症等;中毒;又はこれらの組合せの状態における、請求項1〜12のいずれか一項に記載の使用。
- 前記組成物が、別の免疫強化剤、及び/又は、乳酸菌、ビフィズス菌及び/又は酵母からなる群から選択されることが好ましいプロバイオティクス、及び/又はプレバイオティクス化合物をさらに含む、請求項1〜13のいずれか一項に記載の使用。
- 前記組成物が、鎮痛剤、安定化剤、香味剤、着色剤及び/又は滑沢剤をさらに含む、請求項1〜14のいずれか一項に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08105395.1 | 2008-09-19 | ||
EP08105395A EP2165713B1 (en) | 2008-09-19 | 2008-09-19 | Whey and thymus function |
PCT/EP2009/061876 WO2010031744A1 (en) | 2008-09-19 | 2009-09-14 | Whey and thymus function |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2012502945A true JP2012502945A (ja) | 2012-02-02 |
Family
ID=40342721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011527299A Pending JP2012502945A (ja) | 2008-09-19 | 2009-09-14 | 乳清及び胸腺機能 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8409592B2 (ja) |
EP (2) | EP2165713B1 (ja) |
JP (1) | JP2012502945A (ja) |
CN (1) | CN102186494A (ja) |
AU (1) | AU2009294704A1 (ja) |
BR (1) | BRPI0919319A2 (ja) |
CA (1) | CA2737771A1 (ja) |
DK (1) | DK2337573T3 (ja) |
ES (1) | ES2443965T3 (ja) |
MX (1) | MX2011002980A (ja) |
PT (1) | PT2337573E (ja) |
RU (1) | RU2011115185A (ja) |
WO (1) | WO2010031744A1 (ja) |
ZA (1) | ZA201102911B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011072226A (ja) * | 2009-09-29 | 2011-04-14 | Terumo Corp | 栄養強化用食品素材 |
JP2011072251A (ja) * | 2009-09-30 | 2011-04-14 | Terumo Corp | 術後補助食 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012057636A1 (en) * | 2010-10-27 | 2012-05-03 | Fonterra Corporate Research And Development Limited | Modulation of th1 and th2 immune response by lactic acid whey |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
WO2019036471A1 (en) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002517454A (ja) * | 1998-06-10 | 2002-06-18 | アルバート ビー クラム | 健康保護性腸管ミクロフローラの創造/維持及び免疫系の増強のための予防的及び治療的栄養サプリメント |
JP2002531108A (ja) * | 1998-12-09 | 2002-09-24 | エヌ.ヴイ.ヌトゥリシア | 胸腺の成長を刺激するベビーフード |
JP2004525957A (ja) * | 2001-04-18 | 2004-08-26 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
WO2006084782A1 (de) * | 2005-02-09 | 2006-08-17 | Vifor (International) Ag | Verwendung von eisen(iii)-komplexverbindungen |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1295557A1 (ru) * | 1984-06-05 | 1989-03-30 | Кубанский государственный университет | Способ получени пептидной фракции кумыса,обладающей иммуностимулирующим действием |
EP0322589B1 (fr) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
CA1333471C (en) * | 1988-04-29 | 1994-12-13 | Gustavo Bounous | Whey protein concentrate as food supplement |
US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
FR2711529B1 (fr) | 1993-10-28 | 1996-07-05 | Clintec Nutrition Cy | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
AU692612B2 (en) * | 1994-10-14 | 1998-06-11 | Morinaga Milk Industry Company Limited | Peptide mixture and products thereof |
US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
ATE237957T1 (de) * | 1998-03-31 | 2003-05-15 | Nestle Sa | Verwendung einer zusammensetzung zur versehung von glutamine |
EP1048226B1 (en) * | 1999-04-29 | 2005-08-31 | Société des Produits Nestlé S.A. | Infant formula containing sweet whey protein |
US6833350B2 (en) * | 2000-02-04 | 2004-12-21 | Nestec S.A. | Method for maintaining or improving the synthesis of mucins |
DE60222420T2 (de) * | 2001-07-18 | 2008-06-12 | Dsm Ip Assets B.V. | Verfahren zur hydrolyse von milcheiweissen |
US20070036836A1 (en) | 2003-06-23 | 2007-02-15 | Magali Faure | Amino acid supplementation for a healthy microbiota ecosystem |
US20080108548A1 (en) * | 2004-11-12 | 2008-05-08 | N.V. Nutricia | Food Composition For Rapidly Attenuating Inflammatory Responses |
CN100542430C (zh) * | 2007-05-21 | 2009-09-23 | 北京东方兴企食品工业技术有限公司 | 一种含有益生菌的营养蛋白粉 |
-
2008
- 2008-09-19 EP EP08105395A patent/EP2165713B1/en not_active Not-in-force
-
2009
- 2009-09-14 AU AU2009294704A patent/AU2009294704A1/en not_active Abandoned
- 2009-09-14 CA CA2737771A patent/CA2737771A1/en not_active Abandoned
- 2009-09-14 RU RU2011115185/15A patent/RU2011115185A/ru not_active Application Discontinuation
- 2009-09-14 BR BRPI0919319A patent/BRPI0919319A2/pt not_active IP Right Cessation
- 2009-09-14 CN CN200980141468XA patent/CN102186494A/zh active Pending
- 2009-09-14 MX MX2011002980A patent/MX2011002980A/es active IP Right Grant
- 2009-09-14 PT PT97829717T patent/PT2337573E/pt unknown
- 2009-09-14 US US13/120,118 patent/US8409592B2/en not_active Expired - Fee Related
- 2009-09-14 EP EP09782971.7A patent/EP2337573B1/en not_active Not-in-force
- 2009-09-14 DK DK09782971.7T patent/DK2337573T3/da active
- 2009-09-14 ES ES09782971.7T patent/ES2443965T3/es active Active
- 2009-09-14 WO PCT/EP2009/061876 patent/WO2010031744A1/en active Application Filing
- 2009-09-14 JP JP2011527299A patent/JP2012502945A/ja active Pending
-
2011
- 2011-04-18 ZA ZA2011/02911A patent/ZA201102911B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002517454A (ja) * | 1998-06-10 | 2002-06-18 | アルバート ビー クラム | 健康保護性腸管ミクロフローラの創造/維持及び免疫系の増強のための予防的及び治療的栄養サプリメント |
JP2002531108A (ja) * | 1998-12-09 | 2002-09-24 | エヌ.ヴイ.ヌトゥリシア | 胸腺の成長を刺激するベビーフード |
JP2004525957A (ja) * | 2001-04-18 | 2004-08-26 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
WO2006084782A1 (de) * | 2005-02-09 | 2006-08-17 | Vifor (International) Ag | Verwendung von eisen(iii)-komplexverbindungen |
Non-Patent Citations (2)
Title |
---|
BELABED L ET AL.: "Impairment of lymphocyte function in head-injured rats: effects of standard and immune-enhancing die", CLIN NUTR., vol. 25, no. 5, JPN6013047454, 5 May 2006 (2006-05-05), pages 832 - 841, XP005873945, ISSN: 0002639127, DOI: 10.1016/j.clnu.2006.02.003 * |
NEYCHEV CH ET AL.: "The immunomodulating properties of a glucomacropeptide from whey", ACTA MICROBIOLOGICA BULGARICA, vol. 25, JPN6013047457, 1990, pages 54 - 61, ISSN: 0002639126 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011072226A (ja) * | 2009-09-29 | 2011-04-14 | Terumo Corp | 栄養強化用食品素材 |
JP2011072251A (ja) * | 2009-09-30 | 2011-04-14 | Terumo Corp | 術後補助食 |
Also Published As
Publication number | Publication date |
---|---|
ZA201102911B (en) | 2012-09-26 |
EP2165713A1 (en) | 2010-03-24 |
EP2165713B1 (en) | 2012-11-14 |
WO2010031744A1 (en) | 2010-03-25 |
DK2337573T3 (da) | 2014-01-20 |
CA2737771A1 (en) | 2010-03-25 |
US8409592B2 (en) | 2013-04-02 |
BRPI0919319A2 (pt) | 2015-12-29 |
US20120039944A1 (en) | 2012-02-16 |
EP2337573A1 (en) | 2011-06-29 |
MX2011002980A (es) | 2011-05-10 |
CN102186494A (zh) | 2011-09-14 |
ES2443965T3 (es) | 2014-02-21 |
AU2009294704A1 (en) | 2010-03-25 |
RU2011115185A (ru) | 2012-10-27 |
PT2337573E (pt) | 2014-01-09 |
EP2337573B1 (en) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2495927C2 (ru) | Синбиотическая смесь | |
EP1976397B1 (en) | Infant immunological formula | |
US20120107290A1 (en) | Non-replicating micro-organisms and their immune boosting effect | |
JP2012502945A (ja) | 乳清及び胸腺機能 | |
JP2010535731A (ja) | ラクトバチルスラムノサス及び体重管理 | |
Batiha et al. | Dairy-derived and egg white proteins in enhancing immune system against COVID-19 | |
CN103582426A (zh) | 寡糖混合物以及包含该混合物的食品,特别是婴儿配方产品 | |
US10609945B2 (en) | Compositions comprising 2FL and LNnT to control food intake and growth in infants or young children | |
US20170000810A1 (en) | Nutritional composition to reduce metabolic stress in infants | |
CN110996686A (zh) | 含有人乳低聚糖的营养组合物及其用途 | |
CA2281463A1 (en) | Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics | |
BR112017023636B1 (pt) | Composição oral | |
JP2011519896A (ja) | 唾液分泌を補助するシアル酸 | |
JP5971893B2 (ja) | ミネラル吸収改善剤 | |
AU2012245002A1 (en) | Weight loss composition | |
Walzem et al. | Health enhancing properties of whey proteins and whey fractions | |
EP4068992A1 (en) | Compositions for use in the reduction of pain and/or perception of pain in infants and young children | |
Chandan | Health benefits of yogurt | |
US20230320401A1 (en) | Infant or young child formula | |
RU2801210C2 (ru) | Композиция в форме порошка, содержащая железо и бактерии-пробиотики | |
US11596649B2 (en) | Composition in powder form comprising iron and probiotic bacteria | |
US20220400729A1 (en) | Synergistic combination of butyric-acid-producing prebiotics and probiotics | |
Mc Donagh et al. | Milk and dairy products for better human health | |
BR112019008752B1 (pt) | Composição sob a forma de pó, que compreende complexos de ferroproteína do leite e bactérias probióticas | |
AU2018222626A1 (en) | Nutritional compositions with partially hydrolysed proteins for use in inducing glucose and/or insulin response(s) close to the ones observed with human milk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120911 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131001 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131224 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140107 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140617 |